Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

158 genotypes with 215 annotations displayed of selected term and subterms
Searched Term: abnormal lymphatic vessel morphology
Allelic Composition (Genetic Background)	Annotated Term	Reference
4933434E20Rik^{tm1a(EUCOMM)Wtsi}/4933434E20Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4933434E20Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	enlarged lymphatic vessel	J:239583
Adamts3^tm1.2Itl/Adamts3^tm1.2Itl (involves: BALB/cJ * C57BL/6NTac * SJL)	abnormal lymphangiogenesis	J:245044
	absent lymphatic vessels	J:245044
Angpt1^tm1.1Seq/Angpt1^tm1.1Seq Angpt2^{tm1c(KOMP)Seq}/Angpt2^{tm1c(KOMP)Seq} Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/? Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6NCr)	abnormal lymphatic vessel morphology	J:217296
Angpt2^tm1Gdy/Angpt2^tm1Gdy (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:89618
Angptl4^{Gt(OST352973)Lex}/Angptl4^{Gt(OST352973)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:122968
Angptl4^tm1Lex/Angptl4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:122968
Antxr2^tm1.1Jkit/Antxr2^tm1.1Jkit (involves: 129 * C57BL/6)	lymphangiectasis	J:187210
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Awat2^tm1.2Golc/Y (involves: 129 * C57BL/6 * C57BL/6J)	abnormal lymphangiogenesis	J:308387
Awat2^tm1.2Golc/Awat2^tm1.2Golc (involves: 129 * C57BL/6 * C57BL/6J)	abnormal lymphangiogenesis	J:308387
B9d2^{tm1a(EUCOMM)Wtsi}/B9d2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B9d2^{tm1a(EUCOMM)Wtsi}/Wtsi)	enlarged lymphatic vessel	J:239583
Brd2^{em1(IMPC)Wtsi}/Brd2^{em1(IMPC)Wtsi} (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Casz1^{Gt(CJ0565)Wtsi}/Casz1^{Gt(CJ0565)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:242127
	enlarged lymphatic vessel	J:242127
Ccbe1^tm1Lex/Ccbe1^tm1Lex (involves: 129S5/SvEvBrd)	abnormal lymphangiogenesis	J:186594
Ccbe1^tm1Lex/Ccbe1^tm1Lex (involves: 129S5/SvEvBrd)	absent lymphatic vessels	J:186594
Ccbe1^tm1Mlkn/Ccbe1^tm1Mlkn (either: B6.129-Ccbe1^tm1Mlkn or (involves: 129 * C57BL/6))	absent lymphatic vessels	J:196696
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (involves: 129 * C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:213676
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (B6.Cg-Cdh5^{tm3(Cdh5/Ctnna1)Dvst})	abnormal lymphatic vessel endothelium morphology	J:213676
	abnormal lymphatic vessel morphology	J:213676
Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:165898
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	abnormal lymphatic vessel morphology	J:181715
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	decreased lymphatic vessel endothelial cell number	J:181715
Clec1b^tm1Ksi/Clec1b^tm1Ksi Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:187533
Clec1b^tm1Mlkn/Clec1b^tm1Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
Cmip^{tm1a(EUCOMM)Wtsi}/Cmip^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cmip^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
Col1a1^{tm1(tetO-Cyp26b1)Mfra}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal lymphatic vessel morphology	J:206581
Crim1^{em1(IMPC)Wtsi}/Crim1^{em1(IMPC)Wtsi} (C57BL/6N-Crim1^{em1(IMPC)Wtsi}/WtsiOrl)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel endothelial cell morphology	J:206581
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd Tg(Prox1-EGFP)KY221Gsat/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/NTac)	abnormal lymphatic vessel endothelial cell morphology	J:206581
	abnormal lymphatic vessel morphology	J:206581
Cyp51^tm1.1Bfro/Cyp51^tm1.1Bfro (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:173366
	abnormal lymphatic vessel smooth muscle morphology	J:173366
Del(8A4-B3)7H/+ (involves: 101/H * C3H/HeH)	abnormal lymphatic vessel morphology	J:123074
Dhx35^{tm1b(EUCOMM)Wtsi}/Dhx35^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dhx35^{tm1b(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Dstn^corn1/Dstn^corn1 (A.BY-H2^bc H2-T18^f/SnJ)	abnormal lymphangiogenesis	J:98465
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	abnormal afferent lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: CD-1)	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln Flt4^tm1Ali/Flt4⁺ (involves: C57BL/6)	abnormal afferent lymphatic vessel morphology	J:95885
	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm6Kln/Efnb2^tm6Kln (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:95885
Elk3^tm1Wlyk/Elk3^tm1Wlyk (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	lymphangiectasis	J:71816
Fat1^{Gt(KST249)Byg}/Fat1^{Gt(KST249)Byg} Tg(Myl1-lacZ)1Ibdml/0 (involves: 129P2/OlaHsd)	lymphangiectasis	J:199157
Flt4^Chy/Flt4⁺ (involves: C3H)	abnormal lymphangiogenesis	J:177405
Flt4^Chy/Flt4⁺ (involves: C3H)	abnormal lymphatic vessel morphology	J:72387
Flt4^Chy/Flt4^Chy (involves: C3H)	abnormal lymphangiogenesis	J:177405
Flt4^Chy/Flt4^Chy (involves: C3H)	absent lymphatic vessels	J:177405
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ (involves: 129S/SvEv * C57BL/6)	lymphatic vessel hypoplasia	J:159024
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ Tg(HRAS)2Jic/0 (involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2)	lymphatic vessel hypoplasia	J:159024
Flt4^tm1.2Yhe/Flt4^tm1.2Yhe (involves: 129/Sv * C57BL/6J * FVB/N)	abnormal lymphangiogenesis	J:177405
	absent lymphatic vessels	J:177405
Flt4^tm1Ali/Flt4⁺ Nrp2^tm1Ddg/Nrp2⁺ (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Flt4^tm1Ali/Flt4⁺ Nrp2^tm1Ddg/Nrp2^tm1Ddg (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Flt4^tm1Ali/Flt4⁺ Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Flt4^tm1Ali/Flt4^tm2Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:137909
Flt4^tm2Ali/Flt4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphatic vessel morphology	J:137909
Flt4^tm2Ali/Flt4^tm2Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:137909
Foxc2^tm1.1Miu/Foxc2^tm1.1Miu Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6J * SJL)	abnormal lymphatic vessel morphology	J:316530
Foxc2^tm1Miu/Foxc2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	abnormal thoracic duct morphology	J:83436
	lymphangiectasis	J:83436
	lymphatic vessel hyperplasia	J:83436
Gdf2^tm1Lex/Gdf2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:222016
Gdf2^tm1Lex/Gdf2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	lymphangiectasis	J:222016
Gja1^tm1Kwi/Gja1⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal lymphatic vessel morphology	J:188626
	absent lymphatic vessels	J:188626
Gjb2^{tm3.1(Gjb1)Kwi}/Gjb2⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J * SJL)	abnormal lymphatic vessel morphology	J:188626
Gjb2^{tm3.2(Gjb1)Kwi}/Gjb2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal lymphatic vessel morphology	J:188626
	absent lymphatic vessels	J:188626
Gp6^tm1Beni/Gp6^tm1Beni Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:217963
Gt(ROSA)26Sor^tm1(Ntn4)Dyl/Gt(ROSA)26Sor⁺ Tg(KRT14-cre)1Amc/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal lymphangiogenesis	J:162807
	abnormal lymphatic vessel morphology	J:162807
	lymphatic vessel hyperplasia	J:162807
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Prox1^{tm3(cre/ERT2)Gco}/Prox1⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:158959
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Tbx1^tm3.1Bld/Tbx1^tm6(cre)Bld (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	abnormal lymphatic vessel morphology	J:159824
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor⁺ Tg(CAG-cre/Esr1)5Amc/0 (B6.Cg-Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky} Tg(CAG-cre/Esr1)5Amc)	enlarged lymphatic vessel	J:264410
Heg1^tm1Mlkn/Heg1^tm1Mlkn (either: B6.129-Heg1^tm1Mlkn or (involves: 129 * C57BL/6))	abnormal lymphatic vessel endothelium morphology	J:146528
	lymphangiectasis	J:146528
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal lymphatic vessel morphology	J:119344
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphangiogenesis	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb Tg(KRT14-cre)1Efu/0 (involves: 129S1/Sv * 129X1/SvJ * ICR)	lymphatic vessel hyperplasia	J:154336
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb Tg(Pax6-cre,GFP)1Pgr/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	abnormal lymphatic vessel morphology	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdr^tm1Jrt/Kdr⁺ Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Kdr^tm1Ykub/Kdr^tm1Ykub (Not Specified)	enlarged lymphatic vessel	J:217533
Kdr^tm1Ykub/Kdr^tm1Ykub (Not Specified)	lymphatic vessel hyperplasia	J:217533
Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal lymphatic vessel morphology	J:159024
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(Pf4-icre)Q3Rsko/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(VAV1-cre)1Graf/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:162815
Lgals8^{tm1(KOMP)Vlcg}/Lgals8^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphangiogenesis	J:235778
Lpar4^tm1Sati/Y (involves: C57BL/6)	lymphangiectasis	J:167262
Lpar4^tm1Sati/Lpar4^tm1Sati (involves: C57BL/6)	lymphangiectasis	J:167262
Lyve1^{tm1.1(EGFP/cre)Cys}/Lyve1⁺ Sphk1^tm2Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal lymphatic vessel morphology	J:156826
Lyve1^tm1Lhua/Lyve1^tm1Lhua (B6.129S1-Lyve1^tm1Lhua)	lymphangiectasis	J:117713
Mdfic^em1Nlh/Mdfic^em2Nlh (C57BL/6J-Mdfic^em1Nlh/Mdfic^em2Nlh)	abnormal lymphatic vessel morphology	J:326462
Morc2a^{em1(IMPC)Wtsi}/Morc2a^{em1(IMPC)Wtsi} (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Nf1^tm1Fcr/Nf1^tm1Fcr (either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J))	abnormal lymphatic vessel morphology	J:18048
Nfat5^tm1.1Itl/Nfat5^tm1.1Itl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac * FVB/N)	abnormal lymphatic vessel morphology	J:201429
Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL)	decreased lymphatic vessel endothelial cell number	J:158959
Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL)	decreased lymphatic vessel endothelial cell number	J:158959
Nrp2^tm1.2Mom/Nrp2⁺ Sema3f^tm1.2Ddg/Sema3f⁺ (involves: 129P2/OlaHsd)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Nrp2^tm1.2Mom/Nrp2^tm1.2Mom (involves: 129P2/OlaHsd)	abnormal lymphatic vessel endothelial cell morphology	J:226501
	abnormal lymphatic vessel morphology	J:226501
	lymphatic vessel hyperplasia	J:226501
Nrp2^tm1Ddg/Nrp2^tm1Ddg (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Nus1^tm1Wcsa/Nus1^tm1Wcsa Tg(Cdh5-cre/ERT2)1Rha/0 (Not Specified)	abnormal jugular lymph sac morphology	J:230506
Palm^tm1.2Kili/Palm^tm1.2Kili Tg(Ins2-VEGFC)#Pepr/0 (involves: C57BL/6N)	abnormal lymphangiogenesis	J:237034
Palm^tm1.2Kili/Palm^tm1.2Kili Tg(RIP1-Tag)2Dh/0 Tg(Ins2-VEGFC)#Pepr/0 (involves: C57BL/6J * C57BL/6N * DBA/2J)	abnormal lymphangiogenesis	J:237034
Pdpn^tm1(cre)Mlkn/Pdpn^tm1(cre)Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
Pdpn^tm1Mcws/Pdpn⁺ (involves: 129S6/SvEvTac)	abnormal lymphatic vessel morphology	J:94978
Pdpn^tm1Mcws/Pdpn⁺ (involves: 129S6/SvEvTac)	lymphangiectasis	J:94978
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	abnormal lymphatic vessel morphology	J:94978
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	lymphangiectasis	J:94978
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Tg(CAG-cre/Esr1)5Amc/0 (involves: 129 C57BL/6)	abnormal lymphangiogenesis	J:235778
Pdzk1^{tm2b(EUCOMM)Wtsi}/Pdzk1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pdzk1^{tm2b(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Pik3ca^tm1Jdo/Pik3ca^tm1Jdo (B6.129S7(Cg)-Pik3ca^tm1Jdo)	abnormal lymphangiogenesis	J:122866
Pik3ca^tm1Jdo/Pik3ca^tm1Jdo (B6.129S7(Cg)-Pik3ca^tm1Jdo)	abnormal lymphatic vessel morphology	J:122866
Plcg2^al/Plcg2^al (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:143529
Plcg2^tm1Ichi/Plcg2^tm1Ichi (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:143529
Plxna1^tm1Tmj/Plxna1^tm1Tmj (involves: 129S/SvEv)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Plxna1^tm1Tmj/Plxna1^tm1Tmj (involves: 129S/SvEv)	abnormal lymphatic vessel morphology	J:226501
Plxna2^tm1Hfu/Plxna2^tm1Hfu (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal lymphatic vessel morphology	J:226501
Polb^{tm1a(KOMP)Wtsi}/Polb^{tm1a(KOMP)Wtsi} (C57BL/6N-Polb^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal lymphatic vessel topology	J:239583
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphatic vessel morphology	J:135686
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda Trp53^tm1Sia/Trp53^tm1Sia (involves: various)	abnormal lymphatic vessel morphology	J:135686
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal lymphatic vessel morphology	J:102652
Prox1^tm1Gco/Prox1^tm2Gco Tg(Tek-cre)1Ywa/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	absent lymphatic vessels	J:125507
Prox1^tm1Gco/Prox1^{tm5(GFP/cre)Gco} (involves: 129S1/Sv * 129X1/SvJ * NMRI)	decreased lymphatic vessel endothelial cell number	J:158959
Prox1^tm2Gco/Prox1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * C57BL/6 * NMRI * SJL)	abnormal lymphatic vessel morphology	J:102652
Prox1^tm4.1Gco/Prox1^tm4.1Gco (involves: 129S1/Sv * C57BL/10 * CBA/Ca)	decreased lymphatic vessel endothelial cell number	J:158959
Psph^{tm1a(EUCOMM)Hmgu}/Psph^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Psph^{tm1a(EUCOMM)Hmgu}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	lymphangiectasis	J:44108
Pth1r^{tm1a(EUCOMM)Hmgu}/Pth1r^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pth1r^{tm1a(EUCOMM)Hmgu}/Wtsi)	enlarged lymphatic vessel	J:239583
Ptpn14^{Gt(RRR484)Byg}/Ptpn14^{Gt(RRR484)Byg} (involves: 129P2/OlaHsd)	lymphatic vessel hyperplasia	J:169186
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:119344
Ramp2^tm1Kmca/Ramp2^tm1Kmca (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymphatic vessel morphology	J:130930
Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Rpgrip1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Rr270^em1Mgn/Rr270^em1Mgn (involves: CD-1)	abnormal embryonic lymph sac morphology	J:328045
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg (Not Specified)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg (Not Specified)	abnormal lymphatic vessel morphology	J:226501
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg Sema3g^{tm1(KOMP)Vlcg}/Sema3g^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphatic vessel endothelial cell morphology	J:226501
	abnormal lymphatic vessel morphology	J:226501
	lymphatic vessel hyperplasia	J:226501
Sema3g^{tm1(KOMP)Vlcg}/Sema3g^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphatic vessel morphology	J:226501
Setd5^{tm1a(EUCOMM)Wtsi}/Setd5⁺ (C57BL/6N-Setd5^{tm1a(EUCOMM)Wtsi}/Wtsi)	enlarged lymphatic vessel	J:239583
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Smg9^{tm1b(EUCOMM)Wtsi}/Smg9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smg9^{tm1b(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Sox18^Ra-Op/Sox18^Ra-Op (B6D2-Sox18^Ra-Op/J)	abnormal lymphatic vessel morphology	J:143564
Sox18^tm1Koop/Sox18^tm1Koop (B6.129-Sox18^tm1Koop)	abnormal lymphatic vessel morphology	J:143564
Svep1^{tm1a(EUCOMM)Hmgu}/Svep1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal lymphangiogenesis	J:244466
	abnormal lymphatic vessel morphology	J:244466
Syk^{tm1.1(cre)Fkfr}/Syk^{tm1.1(cre)Fkfr} Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor^tm1(EYFP)Cos (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:159112
Syk^tm1.1Nns/Syk^tm1.1Nns Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/10 * CBA/Ca)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Tie1-cre)9Ref/0 Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1Paw/Syk^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:159112
	abnormal lymphatic vessel endothelium morphology	J:159112
	abnormal lymphatic vessel morphology	J:159112
	enlarged lymphatic vessel	J:159112
	lymphatic vessel hyperplasia	J:159112
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6J)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6J)	decreased lymphatic vessel endothelial cell number	J:181715
Tbx1^tm1Bld/Tbx1^tm1Bld (involves: 129S7/SvEvBrd)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
	lymphangiectasis	J:159824
Tbx1^tm1Bld/Tbx1^tm3Bld Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S7/SvEvBrd C57BL/6 * CBA)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
Tbx1^tm1Bld/Tbx1^tm3Bld Tg(Tek-cre)1Ywa/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
Tent5c^{tm1b(KOMP)Wtsi}/Tent5c^{tm1b(KOMP)Wtsi} (C57BL/6N-Tent5c^{tm1b(KOMP)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0 Tg(Flt4-cre)44Ichi/0 (involves: 129P2/OlaHsd * C57BL/6J)	lymphatic vessel hyperplasia	J:159024
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0 Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	lymphatic vessel hyperplasia	J:159024
Tg(CAG-Has2)99Nita/0 Tg(MMTV-cre)4Mam/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)	abnormal lymphatic vessel morphology	J:130531
Tg(CAG-Has2)99Nita/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul)	abnormal lymphatic vessel morphology	J:130531
Tg(KRT14-FIGF)2Ali/0 (involves: FVB/N)	lymphatic vessel hyperplasia	J:137909, J:68138
Tg(KRT14-FLT4/IGHG1)#Ali/0 (either: (involves: FVB/N) or (involves: BALB/c * DBA))	abnormal lymphatic vessel morphology	J:201429
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	abnormal lymphatic vessel morphology	J:111924
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	enlarged lymphatic vessel	J:92643
Tg(KRT14-VEGFC*)1Ali/0 (involves: FVB/N)	lymphatic vessel hyperplasia	J:68138
Tg(KRT14-Vegfd)1Ali/0 Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB)	abnormal lymphatic vessel morphology	J:137909
Tg(Prox1-EGFP)KY221Gsat/0 (involves: FVB/NTac)	abnormal lymphangiogenesis	J:235778
Tg(Prox1-EGFP)KY221Gsat/0 (involves: FVB/NTac)	abnormal lymphatic vessel endothelial cell morphology	J:235778
Tie1^tm1.1Scba/Tie1^tm1.1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal lymphangiogenesis	J:158668
	abnormal lymphatic vessel morphology	J:158668
	lymphatic vessel hyperplasia	J:158668
Tie1^tm1Geno/Tie1^tm1Geno (involves: ICR)	abnormal lymphangiogenesis	J:159507
Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphangiogenesis	J:159507
Tie1^tm1Scba/Tie1^tm1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphangiogenesis	J:158668
	abnormal lymphatic vessel morphology	J:158668
	lymphatic vessel hyperplasia	J:158668
Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Tmem204^tm1Ali/Tmem204^tm1Ali Tg(Tie1-cre)9Ref/0 (involves: 129S1/Sv * 129X1/SvJ)	enlarged lymphatic vessel	J:159519
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4⁺ (involves: C57BL/6N * C57BL/6NRj)	absent connection between subcutaneous lymph vessels and lymph sac	J:344151
Ube3b^{Gt(RRJ142)Byg}/Ube3b^{Gt(RRJ142)Byg} (involves: 129P2/OlaHsd * CBA/Ca)	lymphangiectasis	J:203652
Vegfa^tm1.1Nagy/Vegfa^tm1.1Nagy (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:64090
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	lymphatic vessel hypoplasia	J:87394
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ)	lymphatic vessel hypoplasia	J:137909
Vegfc^tm1Ali/Vegfc⁺ Tg(KRT14-FIGF)2Ali/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	lymphatic vessel hyperplasia	J:137909
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:87394
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:137909
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:137909
Vegfd^tm1Mach/Vegfd^tm1Mach Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:137909
	abnormal lymphatic vessel morphology	J:137909
Vezf1^tm1Stmn/Vezf1⁺ (B6.129-Vezf1^tm1Stmn)	abnormal lymphatic vessel morphology	J:99326
Zbtb46^tm2.1Mnz/Zbtb46^tm2.1Mnz (involves: C57BL/6)	abnormal lymphangiogenesis	J:191314

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24